Senior citizens will account for nearly one-fifth of China’s population next year, and a third by 2050. Glenn Hassan, CFO & CBO, CANbridge, Joan Kaufman, China health expert and director for academics, Schwarzman Scholars, and Kevin Xie, president at Fosun Healthcare Holdings will explain how the aging trend is driving a massive shift in China’s economy, straining labor and healthcare resources—and fueling new businesses, from luxurious retirement communities to modern medical providers.
Glenn Hassan is Chief Finance Officer and Chief Business Officer at CANbridge. Hassan brings more than 15 years of experience in the healthcare sector globally, as an investor, investment banker, and strategy consultant. Before joining CANbridge, Hassan was a Director, Healthcare Investment Banking at China Renaissance, where he advised Greater China and US life science companies on cross-border M&A and capital raising activities. Previously, Hassan was a Portfolio Manager at Leerink Capital, the investment management division of Leerink Partners, a Boston-based healthcare investment bank.
Prior to Leerink, Hassan was a Senior Analyst at Citadel’s Surveyor Capital, its global equity long/short multi-manager strategy, where he invested in global therapeutic companies and was responsible for more than $250 million in assets. Before Citadel, he was a Senior Healthcare Specialist at Fidelity, where he contributed to the healthcare research effort for the overall Fidelity funds complex and supported the growth of the Fidelity healthcare team’s dedicated assets from less than $10 billion to over $50 billion.
His professional experience also includes strategy consulting and M&A investment banking. Hassan received a Bachelor of Science in Business with a finance concentration from Indiana University and a Master of Science in Global Finance Analysis from Bentley University’s McCallum Graduate School of Business, where he graduated with High Distinction.
Joan Kaufman is the NY–based Senior Director for Academic Programs at Schwarzman Scholars, a newly launched elite international master’s program training future global leaders about China and global affairs at Tsinghua University in China. She is a Lecturer in Global Health and Social Medicine at Harvard Medical School. Dr. Kaufman is a member of the Council on Foreign Relations. An expert on both China and global health policy, she was the Director of Columbia University’s Global Center for East Asia (Beijing) from 2012-2016 and Associate Professor of Health Policy and Management at Columbia’s Mailman School of Public Health. She taught and was based at Harvard’s Kennedy School of Government from 2002-2010 where she founded and directed the AIDS Public Policy Project and was a faculty affiliate of Harvard’s Hauser Center for Non-Profit Organizations. From 2003-2012 she was Distinguished Scientist, Senior Lecturer and Associate Director of the Master Program in Health Policy and Management at Brandeis University’s Heller School for Social Policy and Management. She was a Radcliffe fellow in residence at Harvard from 2001-2002 and named as a Soros Reproductive Health and Rights Fellow in 2005. She has lived and worked in China for 15 years since 1980 as the first international program officer for the United Nations Population Fund (1980-84), as Program Officer for Gender and Reproductive Health for the Ford Foundation (1996-2001), as the China Team Leader for the International AIDS Vaccine Initiative (2002-2012), and for Columbia University (2012-2016). She has a Doctorate in Public Health from the Harvard Chan School of Public Health, an MA and MS (UC Berkeley) and BA (Trinity College) cum laude in Chinese Studies. She serves on the board for several China and health related nonprofits, has consulted for many foundations and international organizations and has published numerous articles on global health policy, HIV/AIDS, women’s rights, reproductive health, population, emerging infectious diseases, and civil society with a focus on China. Her books include A Billion and Counting: Family Planning Campaigns and Policies in the People’s Republic of China (San Francisco Press, 1983) and AIDS and Social Policies in China (Harvard University Asia Center Publications, 2006).
Kevin Xie is the President of Fosun Healthcare Holdings and Chief Representative of Fosun U.S. office. In his current role, Xie is responsible for Fosun Group’s global healthcare investments in both primary and public market. Prior to joining Fosun in 2015, Xie co-founded Locust Walk Capital, a global healthcare hedge fund. Before that, he served as the healthcare sector head at Scopia Capital, a multi-billion USD market neutral long-short equity hedge fund. He was a portfolio manager and managing director at Great Point Partners, a premier healthcare hedge fund / private equity fund. Xie holds an MBA from The Wharton School, a PhD in Chemistry from City University of New York, and a BS in Material Engineering from Tianjin University.